Evidence map›Paper›PMID 38884486›Full record

ArticlemSphere2024

Fecal metagenomic and metabolomic analyses reveal non-invasive biomarkers of

Mio Takeuchi, Erina Fujiwara-Nagata, Kyohei Kuroda, Kenji Sakata, Takashi Narihiro, Jun Kikuchi

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in mSphere, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Mio Takeuchi *Biomedical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Ikeda, Osaka, Japan.ORCID 0000-0003-2183-7371
Erina Fujiwara-Nagata *Department of Fisheries, Kindai University, Nakamachi, Nara, Japan.ORCID 0000-0003-0802-1108
Kyohei KurodaBioproduction Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Sapporo, Hokkaido, Japan.ORCID 0000-0002-3681-1265
Kenji SakataRIKEN Center for Sustainable Resource Science, Yokohama, Kanagawa, Japan.
Takashi NarihiroBioproduction Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Sapporo, Hokkaido, Japan.ORCID 0000-0003-2936-7204
Jun KikuchiRIKEN Center for Sustainable Resource Science, Yokohama, Kanagawa, Japan.ORCID 0000-0002-6809-394X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

With the rapid growth of inland aquaculture worldwide, side effects such as the discharge of nutrients and antibiotics pose a threat to the global environments. A sustainable future for aquaculture requires an effective management system, including the early detection of disease through the monitoring of specific biomarkers in aquaculture tanks. To this end, we investigated whether fish feces in aquaculture tanks could be used for non-invasive health monitoring using ayu ( IMPORTANCE: The aquaculture industry is rapidly growing, yet sustainability remains a challenge. One crucial task is to reduce losses due to diseases. Monitoring fish health and detecting diseases early are key to establishing sustainable aquaculture. Using metagenomic and metabolomic analyses, we found that feces of ayu infected with

Indexed as

AquacultureBiomarkersFecesFish DiseasesFlavobacteriaceae InfectionsFlavobacteriumMetabolomicsMetagenomicsOsmeriformesAnimalsBiomarkersfecal metabolomefecal metagenomefish diseasenon-invasive diagnosissustainable aquaculture

Identifiers

PMID38884486
PMCPMC11288038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.